EUCTR2007-001430-14-IT进行中（未招募）不适用
Peg-filgrastim Vs filgrastrim in pediatric patients. - Peg-filgrastim Vs filgrastrim in pediatric patients.
AZIENDA OSPEDALIERA DI PADOVA0 个研究点开始时间: 2008年1月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-0-17 years old
- •-transplant of autologue CSE
- •-mieloblast ablation with busulfan 16 mg/kg, melfalan 140-200mg/m2,etoposide 40-60mg/kg, cyclofosfamide 120-200 mg/kg,tiotepa 10-15 mg/kg;or radioterapy total body with 12-14.4 Gray.
- •- minimun dose of CD4
- •karnosky score > 90
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-NPT glutamina
- •-terapy with palefermin
- •- others sperimental treatments
研究者
相似试验
已完成
2 期
The comparison of effects of two drugs in neutropenic patientseutropenia.NeutropeniaIRCT201205279875N1Cinnagen Drug Corporation66
进行中（未招募）
不适用
PEG-Filgrastim versus Filgrastim as an adjunct to therapy CHOP-14 Rituximab in elderly patients 60-75 years old with B cell non-Hodgkin s High/intermediate grade lymphoma. A randomized, prospectic, multicenter, open-label, phase II study.Maintenance of dose-intensityMedDRA version: 6.1Level: HLGTClassification code 10025320EUCTR2005-004646-13-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI50
尚未招募
3 期
Comparison of the effect of pegfilgrastim with filgrastim on the neutrophil count of cancer patients under chemotherapy.IRCT20180119038433N3Semnan University of Medical Sciences60
已完成
1 期
The effect of filgrastim and pegfilgrastim in the treatment of fever and immune deficiencyIschemic stroke.Cerebral infarctionIRCT20130812014333N80Vice chancellor for research, Kermanshah University of Medical Sciences100
进行中（未招募）
不适用
Pegfilgrastim versus filgrastim after high-dose chemotherapy followed by autologous peripheral blood stem cell, in patients with hematologic and solid tumors a randomized phase II study - NDPatients with hematological neoplasia or solid tumors treated with high-dose chemotherapyMedDRA version: 6.1Level: HLGTClassification code 10027655EUCTR2006-001409-27-ITISTITUTO CLINICO HUMANITAS80